Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its chiral structure supports selective binding in biological systems, enhancing drug efficacy. Commonly employed in research settings for designing central nervous system (CNS) active compounds due to its ability to cross the blood-brain barrier. Also utilized in the preparation of peptidomimetics for metabolic disease research.